Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.4410
-0.0100 (-2.22%)
At close: Nov 6, 2026, 4:00 PM EST
0.4770
+0.0360 (8.16%)
After-hours: Nov 6, 2026, 7:44 PM EST
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 45 employees as of December 31, 2025. The number of employees increased by 14 or 45.16% compared to the previous year.
Employees
45
Change (1Y)
14
Growth (1Y)
45.16%
Revenue / Employee
$68,156
Profits / Employee
-$54,578
Market Cap
251.38K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | 14 | 45.16% |
| Dec 31, 2024 | 31 | 0 | - |
| Dec 31, 2023 | 31 | -2 | -6.06% |
| Dec 31, 2022 | 33 | 18 | 120.00% |
| Dec 31, 2021 | 15 | -6 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| CDT Equity | 4 |
SCNI News
- 3 days ago - Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands - PRNewsWire
- 19 days ago - Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing - PRNewsWire
- 23 days ago - Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement - PRNewsWire
- 25 days ago - Scinai Immunotherapeutics announces $4M private placement - TheFly
- 25 days ago - Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement - PRNewsWire
- 26 days ago - Scinai signs $5.1M development and clinical manufacturing agreement - TheFly
- 26 days ago - Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics regains Nasdaq compliance - TheFly